June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Comparative Effect of Topical Diclofenac and Topical Dexamethasone on Blood-aqueous Barrier Breakdown and Postoperative Pain following Retinal Detachment Surgery
Author Affiliations & Notes
  • Salim Ben Yahia
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Rim Kahloun
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Nesrine Abroug
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Imen Ksiaa
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Imen Kaibi
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Bechir Jelliti
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Moncef Khairallah
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Footnotes
    Commercial Relationships Salim Ben Yahia, None; Rim Kahloun, None; Nesrine Abroug, None; Imen Ksiaa, None; Imen Kaibi, None; Bechir Jelliti, None; Moncef Khairallah, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5095. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Salim Ben Yahia, Rim Kahloun, Nesrine Abroug, Imen Ksiaa, Imen Kaibi, Bechir Jelliti, Moncef Khairallah; Comparative Effect of Topical Diclofenac and Topical Dexamethasone on Blood-aqueous Barrier Breakdown and Postoperative Pain following Retinal Detachment Surgery. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5095.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare the effect of topical diclofenac and topical dexamethasone on blood-aqueous barrier breakdown and postoperative pain following surgery for rhegmatogenous retinal detachment (RRD).

Methods: The study included 40 eyes of 40 patients treated for RRD. Patients underwent scleral buckling (N=28) or 20-gauge pars plana vitrectomy (PPV) (N=12). For each surgical technique, patients were postoperatively divided into two groups: the first group was treated with topical dexamethasone phosphate 0.1% four times daily for 28 days; the second group was treated with topical diclofenac sodium 0.1% three times daily for 28 days. The inflammatory reaction in the anterior chamber was measured with laser flare photometry preoperatively and 1, 7, 14, 28, and 90 days postoperatively. Pain level was evaluated with Scott’s visual analogue scale at day 1, 7, 14, and 28 postoperatively.

Results: For patients treated with scleral buckling, there was no significant difference between the two groups regarding the mean aqueous flare value at day 1 (p=0.096), day 7 (p=0.435), day 14 (p=0.510), day 28 (p=0.583), and day 90 (p=0.423). The group receiving diclofenac had significantly lower pain score at days 7, 14, and 28 (p=0.048, p=0.017 and p=0.028, respectively). For patients treated with PPV, there was no significant difference between the two groups regarding the mean aqueous flare value at day 1 (p=0.400), day 7 (p=0.728), day 14 (p=0.843), day 28 (p=0.939), and day 90 (p=0.568). Patients receiving diclofenac had significantly lower pain score at days 7, 14, and 28 (p=0.032, p=0.030 and p=0.023, respectively).

Conclusions: Topical diclofenac seems to be as potent as topical dexamethasone in managing inflammatory reaction induced by surgery for RRD with better analgesic effect.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×